KORISSA GILLESPIE: Open Payments
NPI 1376137141 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 31 payments from 12 companies in 2025. Trend: 2023 $1,027 · 2024 $1,166 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $219 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| ABBVIE INC. | 4 | $72 |
| Merz Pharmaceuticals, LLC | 2 | $69 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| SK Life Science, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| JAZZ PHARMACEUTICALS INC. | 1 | $30 |
| Lundbeck LLC | 1 | $30 |
| CSL Behring | 1 | $24 |
Products named: KESIMPTA, INGREZZA, Xeomin, AJOVY, Symbravo, UBRELVY, BOTOX, EPIDIOLEX.
Industry payments across OK — which companies pay providers there.
